Geode Capital Management, LLC My Md Pharmaceuticals, Inc. Transaction History

Geode Capital Management, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 13, 2023	BUY	$0.47 - $1.87 $4,220 - $16,790	8,979 Added 3.18%	291,229 $171,000
Q2 2023 Aug 11, 2023	BUY	$1.44 - $2.26 $8,570 - $13,451	5,952 Added 2.15%	282,250 $423,000
Q4 2022 Feb 13, 2023	BUY	$0.92 - $96.0 $2,988 - $311,808	3,248 Added 1.19%	276,298 $317,000
Q3 2022 Nov 14, 2022	SELL	$2.22 - $82.2 $37,526 - $1.39 Million	-16,904 Reduced 5.83%	273,050 $712,000
Q2 2022 Aug 12, 2022	BUY	$2.0 - $4.78 $8,566 - $20,472	4,283 Added 1.5%	289,954 $629,000
Q3 2021 Nov 12, 2021	BUY	$4.64 - $7.94 $67,688 - $115,828	14,588 Added 5.38%	285,671 $2.06 Million
Q2 2021 Aug 13, 2021	BUY	$3.39 - $6.98 $918,971 - $1.89 Million	271,083 New	271,083 $1.71 Million

30.2K

Ticker MYMD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 39,470,000
Market Cap $67.5M
Description
MyMD Pharmaceuticals, Inc., a clinical development stage pharmaceutical company, focuses on developing various therapeutic platforms to treat the causes of disease. The company is developing MYMD-1, a drug platform based on a clinical stage small molecule that regulates the immune system to control TNF-a, which drives chronic inflammation, and o...

Get notified when there are updates to the investment portfolio of Geode Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Geode Capital Management, LLC with notifications on news.